Skip to main content

ADVERTISEMENT

renal cell carcinoma

01/12/2016
JCP Editors
Cabozantinib improves progression-free survival in patients with advanced renal cell carcinoma, according to an ongoing clinical trial comparing the drug with everolimus, an immunosuppressant that is the current...
Cabozantinib improves progression-free survival in patients with advanced renal cell carcinoma, according to an ongoing clinical trial comparing the drug with everolimus, an immunosuppressant that is the current...
...
01/12/2016
Journal of Clinical Pathways